Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Blood (2024) 143 (18): 1825–1836.

https://doi.org/10.1182/blood.2023019706

Published: 2024

Includes: Supplemental data

Journal Articles

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Blood (2014) 124 (21): 209.

https://doi.org/10.1182/blood.V124.21.209.209

Published: 2014

Journal Articles

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Philippe Armand, Haesook T. Kim, Brent R. Logan, Zhiwei Wang, Edwin P. Alyea, Matt E. Kalaycio, Richard T. Maziarz, Joseph H. Antin, Robert J. Soiffer, Daniel J. Weisdorf, J. Douglas Rizzo, Mary M. Horowitz, Wael Saber

Blood (2014) 123 (23): 3664–3671.

https://doi.org/10.1182/blood-2014-01-552984

Published: 2014

Journal Articles

Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr

William A. Wood, MD, MPH, Stephanie J. Lee, MD, MPH, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Mahmoud D. Aljurf, MD, Karen K. Ballen, MD, David K. Buchbinder, MD, MSHS, Jason Dehn, MPH, CHTC, César O Freytes, MD, Hillard M. Lazarus, MD, Charles F. LeMaistre, MD, Paulette Mehta, MD, MPH, David Szwajcer, MD, FRCPC, Steven Joffe, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2013) 122 (21): 554.

https://doi.org/10.1182/blood.V122.21.554.554

Published: 2013

Journal Articles

Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research

Philippe Armand, MD, PhD, Haesook T. Kim, PhD, Brent R. Logan, PhD, Zhiwei Wang, MS, Edwin P. Alyea, MD, Matt Kalaycio, MD, Richard T. Maziarz, MD, Joseph H. Antin, MD, Robert J Soiffer, MD, Daniel J. Weisdorf, MD, J. Douglas Rizzo, MD, Mary M. Horowitz, MD, MS, Wael Saber, MD, MS

Blood (2013) 122 (21): 548.

https://doi.org/10.1182/blood.V122.21.548.548

Published: 2013

Journal Articles

Older Age, Use Of Myeloablative Regimens For Malignant Diseases and Chronic Graft-Versus-Host Disease Are Risk Factors For Avascular Necrosis Of Bone After Allogeneic Hematopoietic Cell Transplantation In Children and Adolescents

Xianxin Li, MD, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Amal Al-Seraihy, K. Scott Baker, MD, MS, Jean-Yves Cahn, MD, Haydar A. Frangoul, MD, James L. Gajewski, MD, Gregory A. Hale, MD, Jack W. Hsu, MD, Rammurti T. Kamble, MD, Hillard M. Lazarus, MD, Richard T. Maziarz, MD, Bipin N. Savani, MD, Ami J. Shah, MD, Mohamed L. Sorror, MD, MSc, William A. Wood, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2013) 122 (21): 917.

https://doi.org/10.1182/blood.V122.21.917.917

Published: 2013

Journal Articles

Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum?

Rachel J Cook, MD, MS, Zhiwei Wang, MS, Mukta Arora, MD, Hillard M. Lazarus, MD, Kimberly A. Kasow, DO, Martin A. Champagne, MD, FRCPC, Wael Saber, MD, MS, Koen M. Van Besien, MD, Gregory A. Hale, MD, Edward A. Copelan, MD, Mohamed Elmongy, MD, DSc, Naoto T Ueno, MD, Biljana N. Horn, MD, Shimon Slavin, MD, Edward A. Stadtmauer, MD

Blood (2011) 118 (21): 3092.

https://doi.org/10.1182/blood.V118.21.3092.3092

Published: 2011

Journal Articles

Effect of Race on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

Michael J Eckrich, MD, MPH, Kwang W Ahn, PhD, Zhiwei Wang, MS, H. Joachim Deeg, MD, Mary M. Horowitz, MD, Mary Eapen, MBBS

Blood (2011) 118 (21): 1020.

https://doi.org/10.1182/blood.V118.21.1020.1020

Published: 2011

Journal Articles

HLA-matched sibling bone marrow transplantation for β-thalassemia major

Mitchell Sabloff, Mammen Chandy, Zhiwei Wang, Brent R. Logan, Ardeshir Ghavamzadeh, Chi-Kong Li, Syed Mohammad Irfan, Christopher N. Bredeson, Morton J. Cowan, Robert Peter Gale, Gregory A. Hale, John Horan, Suradej Hongeng, Mary Eapen, Mark C. Walters

Blood (2011) 117 (5): 1745–1750.

https://doi.org/10.1182/blood-2010-09-306829

Published: 2011

Journal Articles

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

Navneet S. Majhail, Ruta Brazauskas, J. Douglas Rizzo, Ronald M. Sobecks, Zhiwei Wang, Mary M. Horowitz, Brian Bolwell, John R. Wingard, Gerard Socie

Blood (2011) 117 (1): 316–322.

https://doi.org/10.1182/blood-2010-07-294629

Published: 2011

Journal Articles

CNS Remission at the Time of Autologous Stem Cell Transplantation Improves Outcome for Patients with Non-Hodgkin's Lymphoma with Pre-Existing CNS Involvement: a CIBMTR Analysis

Richard T Maziarz, MD, Mei-Jie Zhang, PhD, Zhiwei Wang, MS, Ginna G. Laport, MD, Hillard M. Lazarus, MD, FACP, Silvia Montoto, MD, Parameswaran Hari, MD

Blood (2010) 116 (21): 371.

https://doi.org/10.1182/blood.V116.21.371.371

Published: 2010

Journal Articles

Bone Marrow Transplantation From HLA-Identical Sibling for Thalassemia.

Mitchell Sabloff, MDCM, FRCPC, MSc, Mammen Chandy, MD, FRACP, FRCPA, Zhiwei Wang, MS, Brent Logan, PhD, Chi-Kong Li, MD, Syed M. Irfan, FCPS, Mary Eapen, MBBS, Mark C. Walters, MD

Blood (2009) 114 (22): 3361.

https://doi.org/10.1182/blood.V114.22.3361.3361

Published: 2009

Journal Articles

Long-Term Survival and Late Relapse in 5-Year Survivors of Allogeneic Hematopoietic-Cell Transplantation (HCT) for Chronic Myeloid Leukemia (CML) in First Chronic Phase.

John M. Goldman, DM, FRCP, FRCPath, Navneet S. Majhail, MD, MS, John P. Klein, PhD, Zhiwei Wang, MS, Kathleen A. Sobocinski, MS, Mukta Arora, MD, Mary M. Horowitz, MD, MS, J. Douglas Rizzo, MD, MS

Blood (2009) 114 (22): 3321.

https://doi.org/10.1182/blood.V114.22.3321.3321

Published: 2009

Journal Articles

Long-Term Survival and Late Deaths in 2-Year Survivors of Myeloablative Allogeneic Hematopoietic-Cell Transplantation for Hematologic Disorders.

John R. Wingard, MD, Navneet S. Majhail, MD, MS, Ruta Bajorunaite, PhD, Zhiwei Wang, MS, Kathleen A. Sobocinski, MS, David Jacobsohn, MD, Mohamed L Sorror, J. Douglas Rizzo, MD, MS, Brian J. Bolwell, Gérard Socié, MD

Blood (2009) 114 (22): 520.

https://doi.org/10.1182/blood.V114.22.520.520

Published: 2009

NARROW

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr

Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research

Older Age, Use Of Myeloablative Regimens For Malignant Diseases and Chronic Graft-Versus-Host Disease Are Risk Factors For Avascular Necrosis Of Bone After Allogeneic Hematopoietic Cell Transplantation In Children and Adolescents

Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum?

Effect of Race on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

HLA-matched sibling bone marrow transplantation for β-thalassemia major

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

CNS Remission at the Time of Autologous Stem Cell Transplantation Improves Outcome for Patients with Non-Hodgkin's Lymphoma with Pre-Existing CNS Involvement: a CIBMTR Analysis

Bone Marrow Transplantation From HLA-Identical Sibling for Thalassemia.

Long-Term Survival and Late Relapse in 5-Year Survivors of Allogeneic Hematopoietic-Cell Transplantation (HCT) for Chronic Myeloid Leukemia (CML) in First Chronic Phase.

Long-Term Survival and Late Deaths in 2-Year Survivors of Myeloablative Allogeneic Hematopoietic-Cell Transplantation for Hematologic Disorders.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only